The India-UK Free Trade Agreement unlocks zero-duty access and faster approvals for Indian pharma exports, paving the way for deeper...

Explore high-impact opportunities as branded and blockbuster drugs lose patent protection in India between 2025-2027. Gain insights into...

India’s New Drugs and Clinical Trials Rules, 2019, mark a significant regulatory shift offering pharmaceutical companies streamlined...

Don’t be fooled by “approved” products without regulatory backing. Your responsibility as a marketer or a pharmaceutical company starts...